Impact of autologous blood injections in treatment of mid-portion Achilles tendinopathy: double blind randomised controlled trial
Authors:
Open Access
Abstract
Objective To assess the effectiveness of two peritendinous autologous blood injections in addition to a standardised eccentric calf strengthening programme in improving pain and function in patients with mid-portion Achilles tendinopathy. Design Single centre, participant and single assessor blinded, parallel group, randomised, controlled trial. Setting Single sports medicine clinic in New Zealand. Participants 53 adults (mean age 49, 53% men) with symptoms of unilateral mid-portion Achilles tendinopathy for at least three months. Participants were excluded if they had a history of previous Achilles tendon rupture or surgery or had undergone previous adjuvant treatments such as injectable therapies, glyceryl trinitrate patches, or extracorporeal shockwave therapy. Interventions All participants underwent two unguided peritendinous injections one month apart with a standardised protocol. The treatment group had 3 mL of their own whole blood injected while the control group had no substance injected (needling only). Participants in both groups carried out a standardised and monitored 12 week eccentric calf training programme. Follow-up was at one, two, three and six months. Main outcome measures The primary outcome measure was the change in symptoms and function from baseline to six months with the Victorian Institute of Sport Assessment-Achilles (VISA-A) score. Secondary outcomes were the participant’s perceived rehabilitation and their ability to return to sport. Results 26 participants were randomly assigned to the treatment group and 27 to the control group. In total, 50 (94%) completed the six month study, with 25 in each group. Clear and clinically worthwhile improvements in the VISA-A score were evident at six months in both the treatment (change in score 18.7, 95% confidence interval 12.3 to 25.1) and control (19.9, 13.6 to 26.2) groups. The overall effect of treatment was not significant (P=0.689) and the 95% confidence intervals at all points precluded clinically meaningful benefit or harm. There was no significant difference between groups in secondary outcomes or in the levels of compliance with the eccentric calf strengthening programme. No adverse events were reported. Conclusion The administration of two unguided peritendinous autologous blood injections one month apart, in addition to a standardised eccentric training programme, provides no additional benefit in the treatment of mid-portion Achilles tendinopathy. Trial registration Australian New Zealand Clinical Trials Registry ACTRN12610000824066, WHO U1111-1117-2641.Keywords
This publication has 44 references indexed in Scilit:
- THE VICTORIAN INSTITUTE OF SPORTS ASSESSMENT - ACHILLES QUESTIONNAIRE (VISA-A) - A RELIABLE TOOL FOR MEASURING ACHILLES TENDINOPATHY2012
- Treatment of Achilles Tendinopathy with Platelet-Rich PlasmaInternational Journal of Sports Medicine, 2010
- Platelet-Rich Plasma Injection for Chronic Achilles TendinopathyJAMA, 2010
- Ultrasound guided dry needling and autologous blood injection for patellar tendinosisBritish Journal of Sports Medicine, 2007
- Mobilisation with movement and exercise, corticosteroid injection, or wait and see for tennis elbow: randomised trialBMJ, 2006
- Medial epicondylitis: is ultrasound guided autologous blood injection an effective treatment?British Journal of Sports Medicine, 2006
- Ultrasound-guided autologous blood injection for tennis elbowSkeletal Radiology, 2006
- Autologous blood injections for refractory lateral epicondylitisThe Journal of Hand Surgery, 2003
- The VISA-A questionnaire: a valid and reliable index of the clinical severity of Achilles tendinopathyBritish Journal of Sports Medicine, 2001
- Regulation of proliferation and osteochondrogenic differentiation of periosteum-derived cells by transforming growth factor-beta and basic fibroblast growth factor.Journal of Bone and Joint Surgery, 1995